Technetium Bicisate
Technetium bicisate (99mTc-ECD) is a lipophilic radiopharmaceutical that crosses the blood-brain barrier and is trapped intracellularly after enzymatic hydrolysis, allowing SPECT imaging of regional cerebral blood flow. It is used in the evaluation of stroke, epilepsy, dementia, and other neurological conditions where cerebral perfusion patterns provide diagnostic information. The distribution of the radiotracer reflects cerebral perfusion at the time of injection.
Terapötik Alanlar
Etki Mekanizması
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
HBD / HBA
- / -
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Sıkça Sorulan Sorular
Technetium bicisate (99mTc-ECD) is a lipophilic radiopharmaceutical that crosses the blood-brain barrier and is trapped intracellularly after enzymatic hydrolysis, allowing SPECT imaging of regional cerebral blood flow. It is used in the evaluation of stroke, epilepsy, dementia, and other neurological conditions where cerebral perfusion patterns provide diagnostic information. The distribution of the radiotracer reflects cerebral perfusion at the time of injection.
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Yes, Technetium Bicisate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4597194. Open-access bioactivity database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="technetium-bicisate"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/technetium-bicisate/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/technetium-bicisate/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/technetium-bicisate/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="technetium-bicisate"></drugfyi-drug>